Albemarle (ALB) Expected to Announce Quarterly Earnings on Wednesday

Key Points

• Albemarle is expected to report Q1 2026 results after the close on Wednesday, May 6; analysts forecast $1.05 EPS and $1.3183 billion in revenue, and the earnings call is set for May 7 at 8:00 AM ET.
• In the prior quarter Albemarle missed EPS estimates (reported -$0.53 vs. consensus -$0.40) while revenue of $1.43 billion beat expectations and rose 15.9% year‑over‑year, signaling mixed operational results.
• Shares opened at $187.08 and were trading down about 6.2%; the company has a market cap of $22.05 billion and a consensus Wall Street rating of Hold with an average target of $178.28.

Albemarle (NYSE:ALB - Get Free Report) is projected to issue its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $1.05 per share and revenue of $1.3183 billion for the quarter. Individuals can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB - Get Free Report) last posted its earnings results on Wednesday, February 11th. The specialty chemicals company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.13). Albemarle had a positive return on equity of 0.41% and a negative net margin of 10.74%.The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the previous year, the firm earned ($1.09) earnings per share. The company's revenue was up 15.9% on a year-over-year basis. On average, analysts expect Albemarle to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Albemarle Trading Down 6.2%

ALB opened at $187.08 on Wednesday. Albemarle has a fifty-two week low of $53.70 and a fifty-two week high of $215.71. The firm has a market capitalization of $22.05 billion, a PE ratio of -32.54, a P/E/G ratio of 1.43 and a beta of 1.43. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.23 and a quick ratio of 1.57. The company's 50-day moving average is $177.51 and its 200 day moving average is $150.91.

Albemarle Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Investors of record on Friday, March 13th were given a dividend of $0.405 per share. The ex-dividend date of this dividend was Friday, March 13th. This represents a $1.62 annualized dividend and a dividend yield of 0.9%. Albemarle's payout ratio is presently -28.17%.

Insider Activity

In related news, CEO J Kent Masters sold 11,783 shares of Albemarle stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $170.81, for a total value of $2,012,654.23. Following the sale, the chief executive officer owned 134,628 shares of the company's stock, valued at approximately $22,995,808.68. The trade was a 8.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.42% of the stock is currently owned by corporate insiders.

Institutional Trading of Albemarle

Several hedge funds have recently made changes to their positions in ALB. BOKF NA boosted its position in Albemarle by 5,771.4% during the third quarter. BOKF NA now owns 411 shares of the specialty chemicals company's stock worth $33,000 after purchasing an additional 404 shares during the period. Los Angeles Capital Management LLC bought a new stake in shares of Albemarle in the fourth quarter valued at approximately $65,000. EverSource Wealth Advisors LLC lifted its stake in shares of Albemarle by 536.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company's stock valued at $36,000 after buying an additional 483 shares in the last quarter. Binnacle Investments Inc lifted its stake in shares of Albemarle by 260.0% during the 3rd quarter. Binnacle Investments Inc now owns 900 shares of the specialty chemicals company's stock valued at $73,000 after buying an additional 650 shares in the last quarter. Finally, Rakuten Securities Inc. boosted its holdings in Albemarle by 57.7% in the 2nd quarter. Rakuten Securities Inc. now owns 1,238 shares of the specialty chemicals company's stock worth $78,000 after buying an additional 453 shares during the period. 92.87% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ALB. Berenberg Bank set a $153.00 price target on Albemarle in a report on Monday, February 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on Albemarle from $185.00 to $195.00 and gave the company a "buy" rating in a research note on Tuesday, February 17th. BMO Capital Markets lifted their price objective on shares of Albemarle from $145.00 to $210.00 and gave the stock an "outperform" rating in a report on Tuesday, January 20th. Bank of America upped their target price on shares of Albemarle from $190.00 to $225.00 and gave the stock a "buy" rating in a research note on Tuesday, April 21st. Finally, JPMorgan Chase & Co. lowered their target price on shares of Albemarle from $195.00 to $145.00 and set a "neutral" rating for the company in a report on Friday, February 13th. Thirteen analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $178.28.

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company's bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world's foremost chemical producers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.